Vaccine Exec Stepping Down and Another Cashing Out
Colluding with the government on a scamdemic pays well. And these two vaccine manufacturer executives have the incomes to prove it.
David Meline came out of retirement to work for Moderna as the companies chief financial officer. Nice job, if you can get it. Especially during a scamdemic.
Based on the disclosure in an SEC filing and Moderna’s 2022 proxy (PDF) statement, Meline enriched himself by $42 million. Meline received 270,000 stock options when he hired on at Moderna in July 2020. So Meline worked less than 2 years, and made millions. Most interestingly, his options don’t fully vest until July 2024. So why leave now, when you bank $20 million annually.
But Melina is leaving. In fact, Moderna revealed that Meline was stepping down. He will be replaced by Jorge Gomez, who leaves his post as CFO at Dentsply Sirona. Gomez, 54, previously served as the finance chief at Cardinal Health.
Meanwhile, Moderna CEO Stephane Bancel has continually sold off 9,000 shares per week of stock for weeks. This amounts to about $6 million per month.
And as the NY Post reported in March,
Moderna CEO Stephane Bancel has sold $408 million in company stock since the start of the coronavirus pandemic, during which the firm’s share price soared more than 600% while it developed and rolled out its vaccine.
The Cambridge, Massachusetts-based biotech firm developed the second-most popular vaccine used to combat COVID-19 in the United States.
The shot jointly developed by Pfizer and BioNTech is the most widely used vaccine in the US.
Since January 2020, Bancel cashed out stock options through the 10b5-1 plan which allows executives to sell a predetermined number of shares at regular intervals to avoid the possibility of insider trading, according to CNBC.
But critics say that 10b5-1 doesn’t allow for transparency since executives aren’t required to disclose these transactions to the Securities and Exchange Commission.
As the old saying goes, “Git it while the gittin’s good!” And that’s what Bancel is doing. In total, Bancel sold more than 2.8 million shares of the company since January 2020.
What about the people Moderna killed or maimed?
What happens to the millions of people negatively impacted by the death pokes of these two companies? In a word: nothing.
Moderna is free to pay crazy executive salaries, and feast on the residuals of the scamdemic with total immunity. A worldwide experiment with humans as lab rats. Sadly, many of these rats voluntarily altered their DNA, putting themselves in the line of fire with no recourse.
Let’s recap.
Meline sold over $42 million in stock. A pittance however, compared to Bancel who sold almost half a billion dollars in stock.
It should be noted that not a single Leftist organization complained about these comp packages. Can you imagine if Trump or Trump cronies pocketed this kind of coin, while killing Americans?
Exactly.
https://theblacksphere.net/2022/07/moderna-ex...shing-out/
Colluding with the government on a scamdemic pays well. And these two vaccine manufacturer executives have the incomes to prove it.
David Meline came out of retirement to work for Moderna as the companies chief financial officer. Nice job, if you can get it. Especially during a scamdemic.
Based on the disclosure in an SEC filing and Moderna’s 2022 proxy (PDF) statement, Meline enriched himself by $42 million. Meline received 270,000 stock options when he hired on at Moderna in July 2020. So Meline worked less than 2 years, and made millions. Most interestingly, his options don’t fully vest until July 2024. So why leave now, when you bank $20 million annually.
But Melina is leaving. In fact, Moderna revealed that Meline was stepping down. He will be replaced by Jorge Gomez, who leaves his post as CFO at Dentsply Sirona. Gomez, 54, previously served as the finance chief at Cardinal Health.
Meanwhile, Moderna CEO Stephane Bancel has continually sold off 9,000 shares per week of stock for weeks. This amounts to about $6 million per month.
And as the NY Post reported in March,
Moderna CEO Stephane Bancel has sold $408 million in company stock since the start of the coronavirus pandemic, during which the firm’s share price soared more than 600% while it developed and rolled out its vaccine.
The Cambridge, Massachusetts-based biotech firm developed the second-most popular vaccine used to combat COVID-19 in the United States.
The shot jointly developed by Pfizer and BioNTech is the most widely used vaccine in the US.
Since January 2020, Bancel cashed out stock options through the 10b5-1 plan which allows executives to sell a predetermined number of shares at regular intervals to avoid the possibility of insider trading, according to CNBC.
But critics say that 10b5-1 doesn’t allow for transparency since executives aren’t required to disclose these transactions to the Securities and Exchange Commission.
As the old saying goes, “Git it while the gittin’s good!” And that’s what Bancel is doing. In total, Bancel sold more than 2.8 million shares of the company since January 2020.
What about the people Moderna killed or maimed?
What happens to the millions of people negatively impacted by the death pokes of these two companies? In a word: nothing.
Moderna is free to pay crazy executive salaries, and feast on the residuals of the scamdemic with total immunity. A worldwide experiment with humans as lab rats. Sadly, many of these rats voluntarily altered their DNA, putting themselves in the line of fire with no recourse.
Let’s recap.
Meline sold over $42 million in stock. A pittance however, compared to Bancel who sold almost half a billion dollars in stock.
It should be noted that not a single Leftist organization complained about these comp packages. Can you imagine if Trump or Trump cronies pocketed this kind of coin, while killing Americans?
Exactly.
https://theblacksphere.net/2022/07/moderna-ex...shing-out/
